On 11 August, Anthropic announced that all future Claude models will generate text that contains a watermark that identifies ...

Gemini and Claude both built impressive offline utility apps, but only one consistently got the details right.

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Who ...

Mindgard used a simple “restore this image” prompt (with no image attached) to see how easily ChatGPT could be steered into unsafe territory. An adversarial testing researcher named Jim Nightingale ...

ChatGPT and Gemini are AI assistants that generate human-like responses to user inputs and help with both complex and everyday tasks. ChatGPT performs better in textual content creation, creative ...

An unexpected recall text message pops up on your phone. It mentions a familiar company like Amazon, a specific order and a possible safety issue. As a result, it is meant to grab your attention fast.

You can now ask the Gemini app to directly generate “downloadable and ready-to-share files.” Google wants you to “quickly move from a brainstorm to a complete ...

The Texarkana Police Department urged residents not to click suspicious links after a strange message claiming to be from the DMV began circulating Getty; Texarkana Texas Police Department/Facebook ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...